Why, if After 7 to 21 Years of Follow-Up Data, Disc Arthroplasty Has a Mere 0.67% Index Level Revision Rate, Is It Not a Standard of Care?

Key Takeaways

• 0.67% index-level revision after up to 21 years
• Adjacent-level surgery only 1.85% over two decades
• One- and two-level TDA show equivalent pain relief
• Prior surgery does not diminish long-term outcomes
• Rapid ODI improvement sustained for 20 years

Pulse Analysis

Lumbar disc arthroplasty entered the market as a motion‑preserving challenger to the long‑standing fusion paradigm, promising to maintain segmental mobility and mitigate adjacent‑segment degeneration. Early adopters were cautious, citing limited follow‑up and concerns about implant wear, facet overload, and the learning curve for multi‑level procedures. Over the past two decades, however, device designs have evolved toward semiconstrained ball‑and‑socket prostheses that better mimic native biomechanics, setting the stage for robust long‑term data.

The recent 1,187‑patient cohort, with an average follow‑up of nearly 12 years and some cases extending to 21 years, provides the most extensive real‑world evidence to date. Patients experienced rapid reductions in ODI and VAS pain scores within three months, and these gains persisted across all subgroups, including those with prior index‑level surgery and those receiving two‑level implants. The index‑level revision rate of just 0.67% and an adjacent‑level surgery rate of 1.85% starkly contrast with fusion series, where adjacent‑segment disease often drives reoperations after a decade. Such durability underscores the potential of TDA to lower lifetime healthcare costs by reducing the need for secondary surgeries.

For spine surgeons and health systems, these findings could shift treatment algorithms toward broader TDA adoption, especially for patients with multi‑segment disease who were previously steered toward fusion. Payers may reassess coverage policies as long‑term cost‑effectiveness becomes clearer. Future research will likely focus on refining patient‑selection criteria, long‑term wear analysis, and comparative effectiveness against emerging minimally invasive fusion techniques, solidifying TDA’s role in the evolving spine‑care landscape.